{"result": "(\"entity\"<|>DC<|>ORGANIZATION<|>DC refers to a dietary therapy used for treating epilepsy, particularly in children with intractable seizures.)\n##\n(\"entity\"<|>EPILEPSY<|>EVENT<|>Epilepsy is a neurological disorder characterized by recurrent seizures, which can be treated with various dietary therapies including the ketogenic diet.)\n##\n(\"entity\"<|>KETOGENIC DIET<|>EVENT<|>The ketogenic diet is a high-fat, low-carbohydrate diet that has been shown to be effective in reducing seizures in patients with epilepsy.)\n##\n(\"entity\"<|>BAILEY EE<|>PERSON<|>Bailey EE is an author who contributed to research on the use of diet in the treatment of epilepsy.)\n##\n(\"entity\"<|>PFEIFER HH<|>PERSON<|>Pfeifer HH is an author who contributed to research on the use of diet in the treatment of epilepsy.)\n##\n(\"entity\"<|>THIELE EA<|>PERSON<|>Thiele EA is an author who contributed to research on the use of diet in the treatment of epilepsy.)\n##\n(\"entity\"<|>MARTIN K<|>PERSON<|>Martin K is an author who contributed to research on the ketogenic diet and other dietary treatments for epilepsy.)\n##\n(\"entity\"<|>JACKSON CF<|>PERSON<|>Jackson CF is an author who contributed to research on the ketogenic diet and other dietary treatments for epilepsy.)\n##\n(\"entity\"<|>LEVY RG<|>PERSON<|>Levy RG is an author who contributed to research on the ketogenic diet and other dietary treatments for epilepsy.)\n##\n(\"entity\"<|>COOPER PN<|>PERSON<|>Cooper PN is an author who contributed to research on the ketogenic diet and other dietary treatments for epilepsy.)\n##\n(\"entity\"<|>KOSSOFF EH<|>PERSON<|>Kossoff EH is an author who contributed to research on dietary therapies for epilepsy.)\n##\n(\"entity\"<|>ZUPEC-KANIA B<|>PERSON<|>Zupec-Kania B is an author who created a keto diet calculator and contributed to research on the ketogenic diet.)\n##\n(\"entity\"<|>KIM DW<|>PERSON<|>Kim DW is an author who contributed to research on the ketogenic diet and its benefits.)\n##\n(\"entity\"<|>KANG HC<|>PERSON<|>Kang HC is an author who contributed to research on complications of the ketogenic diet for intractable epilepsy.)\n##\n(\"entity\"<|>MADY MA<|>PERSON<|>Mady MA is an author who contributed to research on the ketogenic diet for adolescents with epilepsy.)\n##\n(\"entity\"<|>KWITEROVICH PO<|>PERSON<|>Kwiterovich PO is an author who contributed to research on the effects of the ketogenic diet on plasma levels of lipids in children.)\n##\n(\"relationship\"<|>DC<|>EPILEPSY<|>DC is a dietary therapy used to treat epilepsy, particularly in children with intractable seizures<|>8)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>EPILEPSY<|>The ketogenic diet is a specific dietary therapy that has been shown to be effective in reducing seizures in patients with epilepsy<|>9)\n##\n(\"relationship\"<|>BAILEY EE<|>DC<|>Bailey EE is one of the authors who researched the use of diet, including DC, in the treatment of epilepsy<|>5)\n##\n(\"relationship\"<|>PFEIFER HH<|>DC<|>Pfeifer HH is one of the authors who researched the use of diet, including DC, in the treatment of epilepsy<|>5)\n##\n(\"relationship\"<|>THIELE EA<|>DC<|>Thiele EA is one of the authors who researched the use of diet, including DC, in the treatment of epilepsy<|>5)\n##\n(\"relationship\"<|>MARTIN K<|>KETOGENIC DIET<|>Martin K is one of the authors who researched the ketogenic diet and its effectiveness in treating epilepsy<|>5)\n##\n(\"relationship\"<|>JACKSON CF<|>KETOGENIC DIET<|>Jackson CF is one of the authors who researched the ketogenic diet and its effectiveness in treating epilepsy<|>5)\n##\n(\"relationship\"<|>LEVY RG<|>KETOGENIC DIET<|>Levy RG is one of the authors who researched the ketogenic diet and its effectiveness in treating epilepsy<|>5)\n##\n(\"relationship\"<|>COOPER PN<|>KETOGENIC DIET<|>Cooper PN is one of the authors who researched the ketogenic diet and its effectiveness in treating epilepsy<|>5)\n##\n(\"relationship\"<|>KOSSOFF EH<|>KETOGENIC DIET<|>Kossoff EH is one of the authors who researched dietary therapies, including the ketogenic diet, for epilepsy<|>5)\n##\n(\"relationship\"<|>ZUPEC-KANIA B<|>KETOGENIC DIET<|>Zupec-Kania B is the creator of a keto diet calculator and has contributed to research on the ketogenic diet<|>5)\n##\n(\"relationship\"<|>KIM DW<|>KETOGENIC DIET<|>Kim DW is one of the authors who researched the benefits of the ketogenic diet for epilepsy<|>5)\n##\n(\"relationship\"<|>KANG HC<|>KETOGENIC DIET<|>Kang HC is one of the authors who researched complications associated with the ketogenic diet for epilepsy<|>5)\n##\n(\"relationship\"<|>MADY MA<|>KETOGENIC DIET<|>Mady MA is one of the authors who researched the ketogenic diet for adolescents with epilepsy<|>5)\n##\n(\"relationship\"<|>KWITEROVICH PO<|>KETOGENIC DIET<|>Kwiterovich PO is one of the authors who researched the effects of the ketogenic diet on plasma levels of lipids in children<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 2.6.7. Otras complicaciones\n\nDado que los pacientes tratados con DC están en un estado crónico de acidosis, hay riesgo de desmineralización ósea. Por este motivo se aconseja la suplementación rutinaria con calcio y vitamina D. La osteopenia aparece a más largo plazo en un 14,7% de los pacientes. También se ha descrito litiasis renal entre 3,1-6,7% de los pacientes, por lo que se recomienda aumentar de forma preventiva la ingesta de líquidos, dado que no disminuye la eficacia de la dieta6. En un estudio retrospectivo, el uso de citrato potásico se asoció a una prevalencia de litiasis renal 3 veces menor71. Aunque el uso empírico de citratos es razonable, su eficacia en la prevención de litiasis renal no ha sido contrastada en ensayos controlados.\n\n## 3. Resumen y conclusiones\n\nA pesar del volumen de experiencia acumulado con el uso de la DC, solo en los últimos años han aparecido ensayos clínicos aleatorizados que demostraran su eficacia. De hecho, su eficacia es potencialmente mayor que los anticonvulsivantes convencionales en niños con epilepsia intratable y constituyen una buena alternativa terapéutica en estos casos.\n\nSe recomienda un período de prueba de unos 3 meses antes de valorar su eficacia, aunque la mayoría de los casos acostumbran a experimentar mejoría en las primeras 2 semanas. De ser eficaz, la DC se prolonga habitualmente durante 1 a 2 años, procediéndose después a la retirada paulatina de la dieta. Por otra parte, en un porcentaje importante de casos, el uso de la DC ha permitido la reducción o la supresión de la medicación anticonvulsivante. Conviene recordar que la buena adherencia a la dieta determina en gran parte su efectividad.\n\nLa restricción calórica y el control del consumo de líquidos no parecen aportar ventajas en la DC. Igualmente, la fase de ayuno inicial en la DC no es un determinante para la eficacia de la dieta y, en cambio, aumenta la frecuencia de efectos secundarios relacionados con la deshidratación. Para las variantes de la dieta, aquellas que al inicio son más restrictivas en el aporte de glúcidos, parecen dar lugar a mejorías más rápidas, sin encontrarse diferencias a largo plazo. El\n---\n374      BLOQUE: LÍPIDOS\n\ntipo de lípidos aportados en la dieta puede modificar sustancialmente los efectos sobre el perfil lipídico, aunque también puede afectar su palatabilidad y aceptación.\n\nDurante la instauración de la dieta es muy importante una estrecha vigilancia de la glucemia y del estado de hidratación. Durante el seguimiento debe controlarse la evolución pondoestatural y vigilar la aparición de complicaciones. Es importante además la suplementación con vitaminas y minerales para cubrir sus requerimientos. Aunque muy raramente se ha descrito miocardiopatía por déficit de selenio, esta puede ser una complicación potencialmente fatal, por lo que debe extremarse la vigilancia de estos pacientes.\n\n## 4. Bibliografía\n\n1. Bailey EE, Pfeifer HH, Thiele EA. The use of diet in the treatment of epilepsy. Epilepsy Behav. 2005 Feb;6(1):4-8.\n2. Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane database Syst Rev. 2016;2(2):CD001903.\n3. Kossoff EH. More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurol. 2004 Jul;3(7):415-20.\n4. Zupec-Kania B. Keto Diet Calculator [Internet]. Web site. 2017 [citado: 9 Enero 2017]. Disponible en: https://www.ketodietcalculator.org/ketoweb/KetoStart\n5. Kim DW, Kang HC, Park JC, Kim HD. Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics. 2004 Dec;114(6):1627-30.\n6. Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004 Sep;45(9):1116-23.\n7. Mady MA, Kossoff EH, McGregor AL, Wheless JW, Pyzik PL, Freeman JM. The ketogenic diet: adolescents can do it, too. Epilepsia. 2003 Jun;44(6):847-51.\n8. Kwiterovich PO, Vining EPG, Pyzik P, Skolasky R, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 2003 Aug 20;290(7):912-20.\n9. Kang HC, Kim YJ, Kim DW, Kim HD. Efficacy and safety of the ketogenic diet for\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}